CC

Claritev Corporation

CTEV·NYSE

$27.57

-2.7%
HealthcareMedical - Healthcare Information Services

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$470.01M
EPS-17.3000
P/E Ratio-1.59
Earnings Date08/05/2026

ctev

Selling, General and Administrative Expenses

Last Annual Value

221.52M

3-Year CAGR

19%

5-Year CAGR

-9%

10-Year CAGR

11%

CC

Claritev Corporation Competitors Analysis of Selling, General and Administrative Expenses

CTEV · NYSE
CompanySelling, General and Administrative Expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
221.52M
17.7%8.0%N/A 
303.87M
-5.3%6.7%6.6%
LFMD logo
LifeMD, Inc.
NASDAQ:LFMD
144.01M
4.0%3.4%41.5%
34.33M
23.7%77.4%25.7%
AXGN logo
AxoGen, Inc.
NASDAQ:AXGN
142.32M
7.1%6.1%13.9%
699.70M
2.1%1.9%4.4%
44.30M
-15.5%-2.6%N/A
223.00M
-9.5%-13.8%-7.6%
445.52M
-1.5%-3.2%21.3%
35.20M
8.9%11.6%9.6%
CC

Claritev Corporation Fair Value Envelope

CTEV · NYSE

Our analysis suggests that CTEV has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $27.57, this represents a potential HIDDEN relative to our calculated worth for Claritev Corporation.

Intrinsic Value
Current Price: $27.57